Linghui Xia

机构：Union Hospital, Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-7286-3062

发表论文 84 篇 · 总被引 1358 次 · h-index 17

代表论文

• Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update (2024 · Cancer Letters · 被引 128)
• Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group (2024 · Bone Marrow Transplantation · 被引 23)
• SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells (2025 · Leukemia · 被引 12)
• Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis (2023 · Clinical and Experimental Medicine · 被引 10)
• Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2 (2025 · Frontiers in Immunology · 被引 5)
• Humanized anti‐ CD25 monoclonal antibody replaces methotrexate as acute graft‐versus‐host disease prophylaxis in haploidentical allogeneic haematopoietic stem cell transplantation (2024 · British Journal of Haematology · 被引 4)